However, the prognosis for patients with metastatic disease,
localized disease at the axial skeleton (for which surgery is not a
suitable option), or those who are refractory to rst-line
treatments remains particularly dramatic, as second-line treat-
ments fail to offer a meaningful life expectancy for these patients
Çeviri yapılırken hata oluştu. Tekrar hemen çevir butonuna tıklayınız.